Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 857,530 |
|
|||||
| News | - | ||||||
| Day High | 10.535 | Low High |
|||||
| Day Low | 10.01 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.08 | -0.77% | 10.25 | 15:11:08 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.27 | 10.01 | 10.535 | 10.33 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,295 | 857,530 | $ 10.25 | $ 8,790,135 | - | 8.20 - 18.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:11:28 | 1 | $ 10.255 | USD |
iTeos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 363.09M | 35.84M | - | 12.6M | -112.64M | -3.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
iTeos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.22 | 12.37 | 10.01 | 11.00 | 158,560 | -1.97 | -16.12% |
| 1 Month | 11.40 | 13.80 | 10.01 | 12.53 | 280,517 | -1.15 | -10.09% |
| 3 Months | 10.50 | 13.80 | 9.70 | 11.36 | 272,491 | -0.25 | -2.38% |
| 6 Months | 8.87 | 13.80 | 8.53 | 10.68 | 303,721 | 1.38 | 15.56% |
| 1 Year | 13.86 | 18.24 | 8.20 | 11.83 | 357,521 | -3.61 | -26.05% |
| 3 Years | 22.07 | 52.43 | 8.20 | 21.54 | 362,743 | -11.82 | -53.56% |
| 5 Years | 19.70 | 52.43 | 8.20 | 22.70 | 333,014 | -9.45 | -47.97% |
iTeos Therapeutics Description
| ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |
